Literature DB >> 6124581

Regional mapping of neostriatal neurotransmitter systems as a function of aging.

R Strong, T Samorajski, Z Gottesfeld.   

Abstract

The purpose of the present investigation was to map chemically the distribution of certain neurotransmitter systems in the neostriatum of rats aged 6, 16, and 26 months. This mapping was carried out by microdissection of discrete striatal regions coupled with radiometric assays for choline acetyltransferase (ChAT), glutamate decarboxylase (GAD), dopamine (DA), and norepinephrine (NA). In all age groups, ChAT, DA, and NA were highest in the rostral relative to the caudal neostriatum. Additionally, ChAT was higher in the lateral than in the medial region, whereas GAD was more homogeneously distributed within the striatum. ChAT activity was decreased significantly primarily in the caudal regions in rats aged 16 and 26 months. DA levels were decreased in the caudal striatum in rats aged 26 months. NA levels were found to be significantly decreased primarily in the rostral neostriatal regions of the oldest rats. GAD activity remained unchanged in all age groups. These regional changes in selected neurotransmitter systems may underlie specific motor and cognitive deficits that often occur during aging.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124581     DOI: 10.1111/j.1471-4159.1982.tb07967.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Autoradiographic localisation of 3H-apomorphine binding sites in rat brain.

Authors:  M L Bouthenet; N Sales; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

2.  Quantitation of dopamine, serotonin and adenosine content in a tissue punch from a brain slice using capillary electrophoresis with fast-scan cyclic voltammetry detection.

Authors:  Huaifang Fang; Megan L Pajski; Ashley E Ross; B Jill Venton
Journal:  Anal Methods       Date:  2013       Impact factor: 2.896

3.  A novel mouse Chr5 locus Diht controls dopamine-induced hypothermia.

Authors:  Chris W Stoddart; Mathew T Martin-Iverson; Assen Jablensky; Nadezda Urosevi
Journal:  Mamm Genome       Date:  2004-11       Impact factor: 2.957

4.  Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation.

Authors:  T J Collier; C E Sortwell; B F Daley
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

5.  Immunocytochemical study of catecholaminergic neurons in the senescence-accelerated mouse (SAM-P8) brain.

Authors:  N Karasawa; I Nagatsu; K Sakai; T Nagatsu; K Watanabe; M Onozuka
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Participation cholinergic systems of the dorsal and ventral striatum in the training of rats to avoidance in a T-maze.

Authors:  K B Shapalova; V T Shuvaev; I A Zhuravin; E V Pominova
Journal:  Neurosci Behav Physiol       Date:  1996 Jul-Aug

7.  Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging.

Authors:  I Leroux-Nicollet; J Costentin
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Increase in acetylcholine concentrations in the brain of 'old' rats following treatment with pyrithioxin (Encephabol).

Authors:  K J Martin; S Vyas
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

9.  Regional analysis of neostriatal cholinergic and dopaminergic receptor binding and tyrosine hydroxylase activity as a function of aging.

Authors:  R Strong; J C Waymire; T Samorajski; Z Gottesfeld
Journal:  Neurochem Res       Date:  1984-11       Impact factor: 3.996

10.  Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.

Authors:  F M Scalzo; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.